Invention Grant
- Patent Title: EMX2 in cancer diagnosis and prognosis
- Patent Title (中): EMX2在癌症诊断和预后中的作用
-
Application No.: US12701324Application Date: 2010-02-05
-
Publication No.: US09279157B2Publication Date: 2016-03-08
- Inventor: Biao He , David M. Jablons
- Applicant: Biao He , David M. Jablons
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Morrison & Foerster LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; C07H21/04 ; C12P19/34
Abstract:
The present invention provides methods for determining a prognosis of disease free or overall survival in a patient suffering from cancer. The methods generally involve determining a normalized expression level of an EMX2 gene product, which correlates with prognosis and likelihood of survival.
Public/Granted literature
- US20100233703A1 EMX2 IN CANCER DIAGNOSIS AND PROGNOSIS Public/Granted day:2010-09-16
Information query
